ARVN

6.5303.12%
DK

David K. Loomis

VP & Chief Accounting Officer

Mr. David K. Loomis, MBA, is Vice President and Chief Accounting Officer of Arvinas, Inc. He had been Vice President and Chief Accounting Officer of Arvinas, Inc. since December 15, 2022 until 2024 and served as its Corporate Controller until 2024. He served as Corporate Controller at Biohaven Pharmaceutical Holding Company Ltd. since December 2018 until 2022. He serves as Corporate Controller at Biohaven Ltd. He joined Arvinas with finance experience in a broad array of practice and industry, including Big 4 public accounting, financial services, consulting and manufacturing, with the last 15 years spent in the biotech industry. As one of Biohaven’s earliest employees, Mr. Loomis supported Biohaven’s initial public offering, follow-on offerings, intellectual property transactions, establishment of commercial processes and acquisitions, culminating with the sale of Biohaven’s calcitonin gene-related peptide portfolio to Pfizer Inc. Mr. Loomis received his bachelor’s degree and MBA from Quinnipiac University.

Positions